Treatment of acute seizures: is intranasal midazolam a viable option?

Area of Science:

• Pediatric Neurology
• Emergency Medicine
• Pharmacology

Background:

• Pediatric seizures require rapid intervention to prevent neurological damage.
• Rectal diazepam has been the traditional treatment, but alternatives are sought.
• Intranasal midazolam is being investigated as a potentially superior option.

Purpose of the Study:

• To compare the efficacy and safety of intranasal midazolam versus rectal diazepam for acute pediatric seizures.
• To evaluate the cost-effectiveness and pharmacokinetic profiles of both anticonvulsants.
• To assess their utility in prehospital, home, and emergency department settings.

Main Methods:

• Review of existing data on intranasal midazolam and rectal diazepam.
• Comparative analysis of efficacy, safety, cost, and pharmacokinetic properties.
• Focus on pediatric populations experiencing acute seizures.

Main Results:

• Intranasal midazolam presents a viable alternative to rectal diazepam.
• Pharmacokinetic differences between midazolam and diazepam influence their clinical application.
• Data suggests potential advantages in cost and safety for intranasal midazolam.

Conclusions:

• Intranasal midazolam is a promising, potentially more accessible rescue medication for pediatric seizures.
• Further research may solidify its role as a preferred alternative to rectal diazepam.
• This comparison aids clinicians in selecting optimal seizure rescue therapies for children.